Iceland vs Japan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Iceland
0.0%
in 2024
Japan
0.0%
in 2024
Iceland rank
143rd
Japan rank
143rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Iceland
- Japan
How they compare
Iceland currently reports 0.0% against 0.0% in Japan, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Japan ahead.
Iceland ranks 143rd and Japan ranks 143rd of 215 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.0% | 0.0% | Iceland |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Iceland or Japan?
- Iceland, at 0.0% against 0.0% in Japan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Iceland and Japan?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Japan?
- 10 years are reported by both, from 2015 to 2024.
- How do Iceland and Japan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Iceland ranks 143rd and Japan ranks 143rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.